Inventor · disambiguated record
John W. Olney
Also filed as: OLNEY JOHN W
21 granted patents·7 pending applications·1,088 citations·filing 1987–2011
97Inventor score
Top patents by PatentIndex Score
28 records- 0193US5902815AUse of 5HT-2A serotonin agonists to prevent adverse effects of NMDA receptor hypofunctionUNIV WASHINGTON·Filed 1996·Granted May 11, 1999·151 cites·14 claims
- 0292US5925634AUse of ibogaine for treating neuropathic painUNIV WASHINGTON·Filed 1997·Granted Jul 20, 1999·100 cites·5 claims
- 0391US5605911AUse of alpha-2 adrenergic drugs to prevent adverse effects of NMDA receptor hypofunction (NRH)UNIV WASHINGTON·Filed 1995·Granted Feb 25, 1997·130 cites·20 claims
- 0490US5877173APreventing neuronal degeneration in Alzheimer's diseaseUNIV WASHINGTON·Filed 1996·Granted Mar 2, 1999·116 cites·8 claims
- 0584US5958919ATreatment of presymptomatic alzheimer's disease to prevent neuronal degenerationUNIV WASHINGTON·Filed 1996·Granted Sep 28, 1999·75 cites·6 claims
- 0679US5834465ATreatment with combined NMDA and non-NMDA antagonists to reduce excitotoxic CNS damageUNIV WASHINGTON·Filed 1992·Granted Nov 10, 1998·55 cites·17 claims
- 0778US4988710AAryl-cycloalkyl-alkanolamines for treatment of cholinergic neurotoxinsUNIV WASHINGTON·Filed 1989·Granted Jan 29, 1991·53 cites·12 claims
- 0878US4837218AAlkylated bicycloalkaneamines for treatment of neurotoxic injuryUNIV WASHINGTON·Filed 1987·Granted Jun 6, 1989·54 cites·8 claims
- 0973US6391871B1Preventing neuronal degeneration in Alzheimer's diseaseFiled 1999·Granted May 21, 2002·41 cites·17 claims
- 1073US5629307AUse of ibogaine in reducing excitotoxic brain damageFiled 1995·Granted May 13, 1997·35 cites·5 claims
- 1173US5395822AUse of pyruvate to prevent neuronal degeneration associated with ischemiaFiled 1993·Granted Mar 7, 1995·59 cites·12 claims
- 1273US5034400AMethod for preventing neurotoxic side effects of NMDA antagonistsOLNEY JOHN W·Filed 1989·Granted Jul 23, 1991·37 cites·14 claims
- 1370US5474990ABarbiturates as safening agents in conjunction with NMDA antagonistsFiled 1991·Granted Dec 12, 1995·37 cites·16 claims
- 1466US5039528AEAA antagonists as anti-emetic drugsOLNEY JOHN W·Filed 1989·Granted Aug 13, 1991·31 cites·18 claims
- 1563US4833148AMethod of using alkenyl- or alkynyl-substituted thiobarbiturates to reduce neurotoxic injuryUNIV WASHINGTON·Filed 1987·Granted May 23, 1989·28 cites·5 claims
- 1663US4833138APhenothiazinealkaneamines for treatment of neurotoxic injuryUNIV WASHINGTON·Filed 1987·Granted May 23, 1989·27 cites·8 claims
- 1756US2008187605A1Preventing pathological nerve cell suicide (neuroapoptosis) in immature nervous systemsOLNEY JOHN W·Filed 2007·Application pending·0 cites
- 1853US5767130AUse of kainic acid antagonists to prevent toxic side effects of NMDA antagonistsFiled 1995·Granted Jun 16, 1998·15 cites·16 claims
- 1951US4945097AAryl-cycloalkyl-alkanolamines for treatment of neurotoxic injurySEARLE & CO·Filed 1987·Granted Jul 31, 1990·15 cites·9 claims
- 2050US5616580APharmacological composition for preventing neurotoxic side effects of NMDA antagonistsFiled 1991·Granted Apr 1, 1997·12 cites·7 claims
- 2150US5011853ACompounds for treatment of cholinergic neurotoxinsUNIV WASHINGTON·Filed 1990·Granted Apr 30, 1991·14 cites·18 claims
- 2249US2005222270A1Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasisOLNEY JOHN W·Filed 2004·Application pending·0 cites
- 2342US2005148673A1Prolonged administration of NMDA antagonist and safener drug to alter neuropathic pain conditionFiled 2003·Application pending·0 cites
- 2439US2002016319A1Combined adamantane derivative and adrenergic agonist for relief of chronic pain without adverse side effectsFiled 2001·Application pending·0 cites
- 2539US2002068754A1Combination of adrenergic agonist and aryl-cyclo-alkanolamine for relieving chronic pain without adverse side effectsFiled 2001·Application pending·0 cites
- 2639US2002177592A1Combination of adrenergic agonist and tricyclo-alkylamine for relieving chronic pain without adverse side effectsFiled 2001·Application pending·0 cites
- 2738US2012232025A1Safener drug combinations for use with nmda antagonist drugsOLNEY JOHN W·Filed 2011·Application pending·0 cites
- 2835US5037848AAryl-cycloalkyl-alkanolamines for treatment of epilepsyUNIV WASHINGTON·Filed 1989·Granted Aug 6, 1991·3 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when John W. Olney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →